Topical formulations
AssigneeTaraxos Inc.
InventorsRichard WOLICKI, Stanley KIM
Life of this patent
Estimating the term…
Abstract
Topical treatments for neuropathy are described. The treatments include topical formulations of NMDA antagonists and one additional active ingredient. In one example, the formulation includes ketamine and gabapentin for the treatment of a subject's neuropathy. These transdermal or topical compositions provide a surprising degree of effective relief from the symptoms of peripheral neuropathy and can be administered to subjects to treat various neuropathies.
Claims1
A topical composition for the treatment of peripheral neuropathy comprising a therapeutically effective amount of at least one NMDA antagonist and only one additional active compound, wherein the composition is formulated in a pharmaceutically acceptable carrier for topical administration.
Dependencies are inferred from the claim text.